[Code of Federal Regulations]
[Title 10, Volume 1]
[Revised as of January 1, 2001]
From the U.S. Government Printing Office via GPO Access
[CITE: 10CFR35.100]

[Page 568]
 
                            TITLE 10--ENERGY
 
                CHAPTER I--NUCLEAR REGULATORY COMMISSION
 
PART 35--MEDICAL USE OF BYPRODUCT MATERIAL--Table of Contents
 
               Subpart D--Uptake, Dilution, and Excretion
 
Sec. 35.100  Use of unsealed byproduct material for uptake, dilution, and excretion studies.


    A licensee may use for uptake, dilution, or excretion studies any 
unsealed byproduct material prepared for medical use that is either:
    (a) Obtained from a manufacturer or preparer licensed pursuant to 10 
CFR 32.72 or equivalent Agreement State requirements; or
    (b) Prepared by an authorized nuclear pharmacist, a physician who is 
an authorized user and who meets the requirements specified in 
Sec. 35.920, or an individual under the supervision of either as 
specified in Sec. 35.25.

[59 FR 61784, Dec. 2, 1994]